- Home
- MRKR vs STAI Comparison
MRKR vs STAI Comparison
Compare MRKR & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- STAI
- Stock Information
- Founded
- MRKR N/A
- STAI 2011
- Country
- MRKR United States
- STAI United States
- Employees
- MRKR N/A
- STAI N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- STAI
- Sector
- MRKR Health Care
- STAI
- Exchange
- MRKR Nasdaq
- STAI Nasdaq
- Market Cap
- MRKR 19.1M
- STAI 19.0M
- IPO Year
- MRKR N/A
- STAI N/A
- Fundamental
- Price
- MRKR $1.47
- STAI $0.67
- Analyst Decision
- MRKR Strong Buy
- STAI
- Analyst Count
- MRKR 3
- STAI 0
- Target Price
- MRKR $13.17
- STAI N/A
- AVG Volume (30 Days)
- MRKR 231.4K
- STAI 744.5K
- Earning Date
- MRKR 08-13-2025
- STAI 01-01-0001
- Dividend Yield
- MRKR N/A
- STAI N/A
- EPS Growth
- MRKR N/A
- STAI N/A
- EPS
- MRKR N/A
- STAI N/A
- Revenue
- MRKR $5,696,123.00
- STAI $542,166.00
- Revenue This Year
- MRKR N/A
- STAI N/A
- Revenue Next Year
- MRKR $11.28
- STAI N/A
- P/E Ratio
- MRKR N/A
- STAI N/A
- Revenue Growth
- MRKR 71.53
- STAI N/A
- 52 Week Low
- MRKR $0.95
- STAI $0.66
- 52 Week High
- MRKR $5.99
- STAI $9.07
- Technical
- Relative Strength Index (RSI)
- MRKR 50.81
- STAI N/A
- Support Level
- MRKR $1.41
- STAI N/A
- Resistance Level
- MRKR $1.53
- STAI N/A
- Average True Range (ATR)
- MRKR 0.16
- STAI 0.00
- MACD
- MRKR -0.03
- STAI 0.00
- Stochastic Oscillator
- MRKR 9.43
- STAI 0.00
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About STAI ScanTech AI Systems Inc. Common stock
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.